The use of Raman spectroscopy in the detection and classification of malignancy within lymph nodes of the head and neck has been evaluated. Currently histopathology is considered the diagnostic gold standard. A consensus (majority) opinion from three expert histopathologists has been obtained and spectral diagnostic models developed by correlation with their opinions.
INTRODUCTION
Lymph nodes make up only one part of the lymphatic system but they are vital to its function and are distributed throughout he human body. They have several functions; they can act as filters, facilitate lymphopoiesis and the resulting cellular proliferation determines further consequences of lymph node stimulation such as initiation of the immune response.
Lymph nodes have simple connective tissue capsules, afferent and efferent lymphatics and contain the classical spherical arrangement of lymphoid follicles arranged around their periphery within the cortex of the node. The afferent lymphatics enter the node at its outer edge and continue through the paracortical region via a series of anastomosing sinusoids which join together forming medullary sinuses. Efferent lymphatic vessels leave the node at the hilum. Lymph node sinusoids are lined with macrophages which filter material perceived as foreign and help in the initiation of immune responses. Lymphadenopathy is by no means pathonomonic of cancer. Particularly in children enlarged lymph nodes are more often associated with an infective process. Whilst all cells within a lymph node work together in different circumstances certain cell lines predominate. T cells are found in the deeper paracortical areas and will proliferate in response to organisms such as viruses. Secondary follicles are those in which a germinal centre has been formed and in which B cells proliferate; this occurs in response to bacterial infections. Lymph nodes within the head and neck are found grouped in different positions and these are called lymph node levels. This anatomical classification is a very useful tool and is used in subdividing the types of neck surgery used to remove diseased nodes. The number of levels involved in a neoplastic node and whether the disease is unilateral or bilateral will also affect the prognosis.
Cancers which affect lymph nodes are classified as primary, arising from the cells constituting the tissue or they are secondary due to metastatic spread from another site. Of the primary neoplasias the lymphomas are the most common. Hodgkin's lymphoma makes up approximately 0.5% of all cancers presenting each year. In 2004 there were 1519 new cases diagnosed, of these 844 (55.6%) were in men and 675 (44.4%) in women. There are two age ranges were presentation occurs most frequently 15-29 years and 75-84 years. Within these age groups different disease subtypes predominate for example Hodgkin's lymphoma predominates in children and ranks as the 6 th most common cancer in children under 15 years of age 1 . From the mid 1980s to 2003 the age-standardised incidence rates have remained basically unchanged at approximately 3 per 100, 000 male and 2 per 100, 000 for females.
Non-Hodgkin's lymphoma accounts for approximately 4% of all cancers. In 2004, 8316 new diagnoses were made in England. A significantly higher incidence of non-Hodgkin's lymphoma is found in persons over the age of 50 and 69% of diagnoses are made in the over 60s 2 .
Squamous cell carcinoma found within a lymph node in the neck is classified as metastatic disease arising from squamous cells such as those found in the upper aero-digestive tract for example a primary laryngeal cancer. In all regions of the UK men have a significantly greater risk of developing this disease compared to women. The peak age range at which a diagnosis of laryngeal cancer is made in men is 60 -64 years and for women slightly older 65 -69 years. In 2004 there were a total of 2,166 new cases diagnosed in the UK of these 1789 (82.6%) were in men and 377 in women (17.4%). From the early 1990's there has been a decline in mortality in this disease for men and from 2000 this has also been true for women albeit somewhat less pronounced 3 .
Adenocarcinoma can present as both primary head and neck cancers and metastatic deposits within lymph nodes in the head and neck from primary head and neck tumours and further afield such as breast and oesophagus tumours. The external ear 4 and rarely the middle ear 5 contain glandular cells and can therefore be a source of adenocarcinoma. Adenocarcinoma of the external ear is an extremely aggressive disease whereas that of the middle ear has a somewhat better prognosis. Adenocarcinoma of the larynx exists but is very rare, it mainly affects men. About half the patients present with lymph nodes metastases 6 . Salivary adenocarcinomas are once again rare and also have a poor prognosis. In relation to other salivary gland tumours this cancer is one of the more common in children. Adenocarcinoma of the nose and sinuses are uncommon except in people who work within the hardwood industry or in people exposed to Chromium or isopropyl alcohol 7 . In the thyroid papillary adenocarcinoma is the most common tumour and occurs in all age groups including children. Cervical metastatic disease is common and may be principal presenting feature of this cancer. Younger patients tend to have a good prognosis but this decrease with age at presentation. Follicular adenocarcinoma of the thyroid also occurs but interestingly this cancer presents predominately in the over 30s. Cervical lymph node metastases are common and both the primary and metastatic disease readily absorb iodine 8 .
To make a definitive diagnosis and stage a neoplastic disease patients usually require surgical removal of tissue for histological review. A lymph node containing a squamous cell carcinoma must be removed in an extensive surgical 'en bloc' neck dissection to reduce the risk of recurrent local disease. Patients with lymphoma are primarily treated with radio and chemotherapy and a simply lymph node excision is all that is surgically required. If a Raman signal could be used to accurately differentiate between cancers that present in head and neck lymph nodes it has the potential to greatly reduce patient morbidity, improve the speed of diagnosis and reduce costs. This would help move clinical practice to a position where by it can offer treatment plans for cancer sufferers that meet the criteria laid out in the NHS Cancer Plan 9 .
The aim of this work is to assess the ability of Raman spectroscopy to differentiate between normal and diseased lymphoid tissue in the neck. If Raman spectroscopy is a viable tool in this respect then it may be possible to use this technique to introduce a Raman probe by means of a needle obtaining an 'optical biopsy' of enlarged lymph nodes in the neck without surgery. Work has begun on the development of an in vivo probe; however, there is a need to both clarify the validity of the technique when applied to this type of tissue and to formulate a baseline set of spectra for different lymphoid diseases.
Raman spectroscopy of lymph node tissue
The study of lymph nodes containing neoplastic tissue using Raman spectroscopy has been limited, most have been associated with the investigation of metastatic breast adenocarcinoma. Other studies have shown the ability of Raman spectroscopy to interrogate lymph nodes for the presence of silicone in patients who have undergone breast augmentation 10, 11 . Raman was first used to study breast cancer 12 in 1991 and has now been successfully used in vitro to detect the presence of lymph node metastases from breast cancer 13, 14 . More recently in vivo experiments have been undertaken on mice using Raman spectroscopy to differentiate between normal breast tissue and that infiltrated with tumour 15, 16 . Kast et al extended their study to also investigate metastatic breast disease in regional lymph nodes groups. With spectral classification of normal, tumour and inflammatory tissue correlating well with results obtained from histological analysis.
Investigative techniques for lymphadenopathy

Histopathology and Immunohistochemistry
Lymphoma cannot be reliably diagnosed from tissue frozen sections and requires paraffin sections so for a definitive diagnosis assessment of an excised lymph node is required. The histological feature which identifies Hodgkin's lymphoma rather NHL is the presence of Reed-Sternberg cell.
There are five sub-groups of Hodgkin's lymphoma defined histologically;
The majority of early Hodgkin's lymphoma is of the nodular-sclerosing (NS) and mixed-cellularity (MC) types. There is now scope within this classification for the presence of a lymphocyte predominant (LP) subgroup which in the early stages has an excellent response to treatment. The histological definition of NHL subgroups is difficult and immunohistochemistry is very useful in determining phenotype. If certain markers are present for example κ or λ light chains the presence of NHL is confirmed differentiating the node from a purely reactive one. This is off great importance particularly in children who often present with non-specific lymphadenopathy. Analysis of tumour cell antigens, immunoglobulin and T-cell receptors may also be useful. Cryogenetics, the study of specific chromosomal translocations is a relatively new and exciting field, certain translocations may be important in the diagnosis and prognosis of NHL 17 .
Computed Tomography Scanning (CT) and Magnetic Resonance Imaging (MRI)
CT is low in cost and widely available. The advent of spiral-CT scanning allows three dimensional reconstruction and is likely to play an increasingly important rôle 18 . One way to achieve this may be the development of a computer tomography virtual endoscopy (CTVE) 19, 20 . MRI and CT have historically been seen as competitors. MRI facilitated multiplanar imaging earlier than CT scanning and produces better delineation of soft tissue 21 . Its ability to delineate the extent of disease allows for accurate staging and improved operative planning. This type of scanning is non-invasive and probes tissue by determining the movement of water.). Imaging plays a vital rôle in staging of lymphoma. CT scanning of the chest and thorax has largely superceded the use of chest x-ray and is done for both staging and to monitor response to treatment. MRI scanning is commonly utilised and in certain centres full body PET scanning is used in the staging of both non-Hodgkin's and Hodgkin's lymphoma. It is particularly useful in combination with CT for the detection of small residual tumour masses post treatment. Bone scans can also be useful in detecting extralymphatic deposits.
Scintigraphy and Super-imposed Dual Isotope Scanning (SPECT)
99mTc-tetrofosim scintigraphy has been investigated as a possible way of staging cancer 22 . This study compared the results of scintigraphy with those obtained from CT scanning. Both modalities were found to be equally sensitive (96%) for identification of the primary tumour. CT was significantly more sensitive in detecting lymph nodes containing metastatic disease (100% vs. 50%) however the specificity of 99mTc-tetrofosim scintigraphy was much higher than CT scanning (100% vs. 56%).
Cytology
Fine needle aspiration cytology is a technique where by cells are removed percutaneously from suspicious tissue. It is performed on all neck nodes at presentation and usually in the outpatient clinic. The technique has limitations, poor operator technique, variability in the skills required to interpret the slides and limitations on the information available to diagnose certain neoplasias such as lymphoma. FNAC cannot be used to definitively diagnose lymphoma however there are features that would alert an experienced cytologist the possibility of this as a diagnosis. FNAC is much more useful in the presence of carcinoma. Flow cytometric analysis has recently also been used to diagnosis carcinoma occurring in head and neck tissue 23 . In this study DNA image cytometry was used to assess if DNA ploidy could predict clinical outcome. Imprint cytology has also been mooted as future diagnostic technique 24 . The results of this study appeared very promising however the inherent drawbacks of cytology, inter-observer error and error induced by poor handling and preparation of the tissue, remain problematic.
Molecular biology
There has been a great deal of interest in the use of molecular biology in the study of head and neck cancers. Investigation of tumour biology has concentrated on analysis of treatment results and the search for prognostic indicators. This is a huge area of ongoing work and as yet no single test has been found. It is known that over expression of the p53 gene at the edges of resected laryngeal cancers which macroscopically appeared free from disease reflects a similarly poor prognosis to those specimens resected with positive margins 25 .
Positron Emission Tomography (PET) scanning
PET scanning is based on the detection of a radioactive tracer which is introduced to the body intravenously and can be varied depending on which tissue is under investigation. PET scanning can be used to assess physiological function such as blood flow and metabolism. Using a fluorine 18 radioactive glucose analogue, 18-fluorooxyglucose, the rate of cellular glucose consumption can be measured and used to distinguish between malignant and benign tissue in the head and neck 26, 27 . This type of scan is not widely available and the equipment expensive however it is now used in specific areas such as the detection of occult head and neck malignancy particularly in patients who have radionecrosis and/or surgical scarring and in whom clinical assessment can be very difficult. The lack of PET scanners in the UK means many suitable patients still undergo CT scanning as an alternative.
The efficacy of different imaging modalities for the detection of metastatic lymph node disease arising from a primary tumour in the larynx has been studied 28 . In this study CT and MRI scanning were felt to be superior to neck palpation. Ultrasound examination also appeared slightly better, PET scanning and ultrasound guided fine needle aspiration cytology gave the best results.
Colour Duplex Echography
Colour duplex echography is not widely used in the UK but is in the United States as a way of assessing blood flow 29 . This study assessed the ability of colour duplex echography to help distinguish the margins of malignant tissue within the head and neck. It was noted that the central portion of tumours where relatively poorly vascularised compared with those seen at the periphery of the lesion and it was felt that this technique would only be a useful adjunct to other staging procedures.
Haematological and Biochemical Tests
Haematological and biochemical tests used for staging some neoplastic disease such as lymphoma include full blood count (FBC), erythrocyte sedimentation rate (ESR), liver function tests, lactate dehydrogenase (LDH) and C-reactive protein measurements.
Surgery
Surgery at present is mandatory before treatment to obtain a definitive diagnosis through histological and immunohistological analysis of affected lymphoid tissue although in some cases a tru-cut biopsy of a prominent lymph node may be needed. In the past for full pathological staging of lymphoma a bone marrow trephine was taken from the iliac crest and diagnostic laparotomy performed with splenectomy. Clinical assessment is thought to underestimate the amount of abdominal involvement in a large percentage of patients with clinical stage (CS) I and II of Hodgkin's disease but there is no recorded improvement in survival in patients who have undergone staging with laparatomy so this has now been abandoned 30 .
METHODOLOGY
Acquisition of tissue specimens
All tissue used in this work was obtained by the primary author, assisted by Mr. M Thomas, consultant ENT surgeon, Gloucestershire NHS Trust (GNHST) during elective surgical procedures. These procedures were performed under general anaesthetic in accordance with an approved ethical proposal. At all times the General Medical Council (GMC) Guidelines on good clinical practice were followed.
The patient was positioned prone, the head resting in a gel ring or pillow, neck extended and head turned towards the unaffected side if the lesion was unilateral or with the head held centrally if the operation was bilateral. A skin incision was marked and the appropriate operation performed to remove the diseased tissue (see Figure 1 ). Biopsies were obtained from as many separate enlarged nodes as possible and each assigned a side and anatomical level. Only specimens located away from areas where bipolar diathermy had been used for haemostasis were included. 
Specimen Processing
Research biopsies were placed on acetate paper and wherever present the capsule of the node was placed upper most next to a mark on the paper in order that orientation could be maintained throughout processing. Each specimen was placed in a labelled cryo-vial. The specimens were snap frozen in liquid nitrogen. A card was written at the time of surgery identified the exact location on the main specimen from which each biopsy had been taken and this card placed in the patient's research file. A comment was made on the histopathology request form sent to keep the reporting pathologist informed.
For every specimen histological tissue cross sections were obtained and H&E slides of the frozen section made. Distortion of spectra from the contamination that occurs during normal histological processing 31 was avoided by obtaining H&E slides from the frozen sections using a freezing microtome. The acetate paper on which the specimen was mounted in the operating theatre acted not only to orientate the sample but also allowed the specimens to adhere to the microtome chuck without the need for cutting agents. Ice crystal artefact was avoided throughout by snap freezing the specimens using liquid nitrogen.
The freezing microtome was used to obtain a 7 micron section which was mounted on a plain glass slide for H&E staining. All H&E slides were assessed by three histopathologists independently. Those specimens identified from frozen sections as lymphomas were further subdivided (Hodgkin's and non-Hodgkin's) using the paraffin sections obtained from the rest of the node (lymphoma type is difficult to distinguish in frozen sections). The blocks of tissue remaining were mounted on CaF 2 slides were stored at -85°C and before being used in any of the Raman experiments were allowed to passively thaw at 23°C.
Spectrometer
A customized Raman spectrometer system based on the commercially available Renishaw System 1000 microspectrometer coupled with an excitation source and confocal, polarized light microscope (Leica DML) was used in this work. The laboratory environment closely monitored and kept at 23 o C. The excitation source used was a 300mW 830nm stabilised semiconductor laser (Renishaw). Work has shown that using 830nm is the optimum excitation source wavelength for measuring the Raman spectra from biological tissue such as that obtained from the larynx 32, 32 and from lymph node tissue 34 . An 80x (Olympus) ultra-long-working-distance (ULWD) objective was to focus the illumanition and collect the scattered light 35 . A 300 lines/mm grating and a pair of edge filters (Semrock) were used to separate the Raman from the elastically scattered light and to disperse the spectrum across the deep depletion CCD detector. This was Peltier cooled to -70 o C to reduce thermal noise.
Full wavenumber and energy sensitivity calibrations were undertaken. Wavenumber calibration was performed using a neon-argon atomic emission lamp standard. For the daily calibration of wavenumber silicon, cyclohexane and polymer standards were used. Energy sensitivity calibration was achieved by comparing the ratio of the measured and calibrated standard spectra (NPL, UK) from a tungsten filament lamp to provide an instrument response profile. This and used to correct spectra obtained from tissue specimens.
Specimen Presentation and Acquisition of Spectra
Specimens used in this study were individually mounted in their anatomical position on CaF 2 slides and held oriented in the correct position by two other pieces of CaF 2 . CaF 2 was used for this purpose as it has a well defined spectrum with only one Raman peak at 323cm -1 which falls outside the wavenumber range being studied (400-1800 cm -1 ). The CaF 2 unit was placed on the microscope presentation stage and by moving the stage up or down a basic focus was achieved which was fine tuned by using the microscope manual controls. Multiple point spectra were obtained in a step wise progression across the specimen by moving the presentation stage. The excitation source used provided light with a wavelength of 830nm, the spectra acquisition time was set at 10 seconds. The range over which scattered light was detected was approximately 200-2000 wavenumbers (cm -1 ). 
DATA ANALYSIS
Following correction of the spectra for the energy sensitivity of the system using the protocol outlined above, spectra were normalized and mean centred. Data was coded for consensus (majority) histopathology and the principal component fed linear discriminant analysis was performed. The first 25 PCs (describing 99% of the variance) were used to calculate the LD functions for discrimination. The models were tested using leave one sample out cross-validation. Figure 2 shows the mean normalized spectra measured from the five pathology groups included in this study. The mean spectra show many similarities mainly from similar protein, lipid, amino acids, carbohydrates and nucleic acid content, with subtle changes observed between the pathology groups. The spectra were combined into a two group model initially to demonstrate the ability of Raman spectral discrimination of benign and cancer positive nodes of all types. The 2 group model when tested with leave one sample out cross-validation achieved 89% correct prediction of pathology. The detailed break down of results can be found in Tables 2 and 3 . Figure 2 shows the mean normalized spectra measured from the five pathology groups included in this study. The data was also used to construct and test a four group model to discriminate the key pathologies from the reactive nodes. The resulting linear discriminant model scatter plot is shown in Figure 3 . The leave on e sample out cross validation performance of the model is shown in Tables 4 and 5 . Overall performance was 84% by node. 
RESULTS
